Filing Details

Accession Number:
0000898432-19-001329
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 17:25:53
Reporting Period:
2019-11-21
Accepted Time:
2019-11-22 17:25:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254747 Brent Johnson C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
Exec. Vp Of Ww Sales And Mktg No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-21 6,000 $0.93 7,368 No 4 A Direct
Common Stock Disposition 2019-11-21 6,000 $23.28 1,368 No 4 S Direct
Common Stock Acquisiton 2019-11-22 6,000 $0.93 7,368 No 4 A Direct
Common Stock Disposition 2019-11-22 6,000 $23.25 1,368 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-21 6,000 $0.00 6,000 $0.93
Common Stock Stock Option (Right to Buy) Disposition 2019-11-22 6,000 $0.00 6,000 $0.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,160 2021-12-27 No 4 M Direct
4,160 2021-12-27 No 4 M Direct
Footnotes
  1. The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
  2. This transaction was executed in multiple trades at prices ranging from $23.20 to $23.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.